The multifunctional pattern recognition scavenger receptors, SR-A and CD36, are predominantly expressed by lamina propria macrophages and considered important in innate immunity. We examined the role of these receptors in the pathophysiology of inflammatory bowel disease. Colitis was induced in wild type (WT), SR-A−/−, CD36−/−, and SR-A/CD36 double deficient mice by administering DSS. DSS-induced moderately severe colitis in WT mice was manifested by weight loss, reduced hematocrit, and pathology. SR-A/CD36 double deficient mice developed significantly more severe colitis as indicated by anemia (P < 0.01), decreased colonic length due to inflammation (P < 0.01), and lesions when compared with WT and single deficient animals. Serum amyloid A was significantly more elevated in SR-A/CD36−/− mice (P < 0.01) compared with WT and single deficient animals. However, the spleens of WT mice (P < 0.05) were significantly enlarged. Inflammatory cytokine levels were considerably increased in WT mice (IL-6 P < 0.001, TNFα P < 0.01). In contrast, SR-A deficient mice maintained more normal body and splenic weight and developed less severe colonic lesions compared to other groups. In conclusion, our data indicate that SR-A/CD36 double deficiency leads to more severe colonic lesions and dysregulated inflammatory response as compared with single SR-A or CD36 deficiency in colitis, suggesting additive effects between these two receptors in this model.
Scavenger receptors Macrophages SR-A CD36 Colitis
Dextran sodium sulphate
Scavenger receptor A
Tumor necrosis factor
This is a preview of subscription content, log in to check access.
This study was partially supported by the National Institutes of Health grant NCCAM-AT1490 and NCRR P20RR020145,COHR-Pilot Project (H. S. Oz).
Guidez F, Li AC, Horvai A, Welch JS, Glass CK. Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol Cell Biol. 1998;18:3851–3861.PubMedGoogle Scholar
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79–82. doi:10.1038/34178.CrossRefPubMedGoogle Scholar
Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001;108:785–791.PubMedGoogle Scholar
Ockenhouse CF, Chulay JD. Plasmodium falciparum sequestration: OKM5 antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line. J Infect Dis. 1988;157:584–588.PubMedGoogle Scholar
Van Lenten BJ, Fogelman AM. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte–macrophages is mediated through tumor necrosis factor-alpha. J Immunol. 1992;148:112–116.PubMedGoogle Scholar
Areschoug T, Waldemarsson J, Gordon S. Evasion of macrophage scavenger receptor A-mediated recognition by pathogenic streptococci. Eur J Immunol. 2008;38:3068–3079.CrossRefPubMedGoogle Scholar
Suzuki H, Kurihara Y, Takeya M, Kamada N, Kodama T, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386:292–296. doi:10.1038/386292a0.CrossRefPubMedGoogle Scholar
Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, El Khoury J. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med. 2000;191:147–156.CrossRefPubMedGoogle Scholar
Haworth R, Platt N, Keshav S, et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med. 1997;186:1431–1439.CrossRefPubMedGoogle Scholar
Kobayashi Y, Miyaji C, Watanabe H, et al. Role of macrophage scavenger receptor in endotoxin shock. J Pathol. 2000;192:263–272.CrossRefPubMedGoogle Scholar
Hagiwara S, Takeya M, Suzuki H, et al. Role of macrophage scavenger receptors in hepatic granuloma formation in mice. Am J Pathol. 1999;154:705–720.PubMedGoogle Scholar
Takeda N, Manabe I, Shindo T, et al. Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6. Arterioscler Thromb Vasc Biol. 2006;26:1177–1183.CrossRefPubMedGoogle Scholar
Mytar B, Woloszyn M, Macura-Biegun A, et al. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells. Anticancer Res. 2004;24:2287–2293.PubMedGoogle Scholar
Li WX, Howard RJ, Leung LL. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J Biol Chem. 1993;268:16179–16184.PubMedGoogle Scholar
Fadok VA, Warner ML, Bratton DL, Henson PM. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha vs. beta 3). J Immunol. 1998;161:6250–6257.PubMedGoogle Scholar
Stolzing A, Grune T. Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells. FASEB J. 2004;18:743–745.PubMedGoogle Scholar
Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995;181:1857–1862.CrossRefPubMedGoogle Scholar